Cagent Vascular
PrivateLast Round
Series D
May 19, 2026
Total Funding Raised
$113.92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cagent Vascular is a medical device company that develops and commercializes intravascular technology for the treatment of peripheral artery disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cagent Vascular Comparables
Compare Cagent Vascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flex Vascular | 88% | |
| Johnson & Johnson | 80% | |
| Elixir Medical Corporation | 78% |
Cagent Vascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 19, 2026 | ||||
| Debt | Feb 20, 2025 | ||||
| Series C | Feb 19, 2024 | ||||
| Series B Extension | Jun 17, 2021 | ||||
| Series B | Jul 12, 2018 | ||||
Series A | Feb 28, 2017 |
Key People
Founding team and executive leadership
Cagent Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Series A, Series B |
| Tech-Synergy | Series B |
| U.S. Venture Partners | Series D, Series C |
| Synergy Ventures | Series B |
| Astoria Health Investors | Series D |
| Trinity Capital | Debt |
| Sectoral | Series C, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 153% MoM, reaching 4.2K.
- May 19, 2026
$41M round led by Astoria Health Investors and U.S. Venture Partners
Cagent Vascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cagent Vascular's valuation, stock price, and market status.
Is Cagent Vascular a public or private company?
Cagent Vascular is a private company.
What is the current stock price of Cagent Vascular?
Cagent Vascular is a private company with no public stock price. No recent secondary market data is available.
How much is Cagent Vascular worth (valuation)?
Valuation information for Cagent Vascular is not publicly available.
Can I buy Cagent Vascular stock?
Cagent Vascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cagent Vascular's last funding round?
Cagent Vascular's most recent funding round was Series D on May 19, 2026.
Who are the main investors in Cagent Vascular?
Key investors in Cagent Vascular include U.S. Venture Partners, Astoria Health Investors, Sectoral.
Will Cagent Vascular IPO soon?
No public IPO plans have been announced for Cagent Vascular.
How can I track Cagent Vascular secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cagent Vascular's secondary market activity and sign up for updates.